IP and R&D Spark Newsletter

This month’s Legal Watch tracks critical rulings and evolving procedural frameworks that continue to reshape the IP landscape. The Federal Circuit rules that jurisdiction cannot be invoked in cases that do not raise substantive patent law issues, reinforcing limits on appeal rights. In a notable policy move, the USPTO Director blocks post-grant patent challenges involving the “settled expectations” of older patents, signaling more protection for legacy IP holders. The EPO updates its DOCX filing standards, while the Egenera v. Cisco case adds nuance to how internal decision-making documents are interpreted during litigation.

In Industry News, the Trump Administration signals a bold shift by considering a value-based patent fee overhaul aimed at boosting agency revenue and improving application efficiency. Meanwhile, tech companies increasingly turn to rare legal strategies to contest USPTO review denials. Europe sees a landmark moment with EPO Decision G 1/23, which expands the boundaries of what constitutes prior art. South Korea tightens enforcement with stronger penalties for trademark and design infringement, reinforcing regional IP protection frameworks.

This month’s Techno Spotlight showcases a diverse mix of frontier science and market-moving tech. In chemicals and materials, researchers turbocharge photosynthesis with reengineered rubisco, convert CO₂ into synthetic fuel, and harness lightning to produce green ammonia. A newly created compound challenges foundational chemistry principles. In life sciences, the spotlight turns to next-gen obesity drugs, breakthrough blood-based cancer detection, lung-on-a-chip innovations, and the discovery of a mitochondrial “sleep switch.” Hi-tech headlines include interactive quantum computing platforms, advances in semiconductor discovery, and curved neural networks mimicking human memory. The consumer sector heats up with M&A activity — from Reckitt’s divestment to Ferrero’s acquisition of WK Kellogg Co. — and stress-induced hunger finds a new combatant in a plant-based drink. On the regulatory front, the UK investigates GLP-1 drug safety, Novartis advances newborn malaria treatment, and the FDA approves a new oral therapy for HAE. Meanwhile, early lead exposure is linked to accelerated memory decline in children, raising fresh public health alarms.
In mobility and mechanics, Huawei patents an EV battery promising a 3,000 km range, while robotaxis gain traction with Tesla and cost-cutting Chinese entrants. Jungo secures a new patent for adaptive vehicle monitoring, and Bugatti goes ultra-premium with a sound system that doesn’t use traditional speakers. On the standards front, SEP licensing continues to evolve: the U.S. rejects Roku’s global FRAND rate-setting attempt, the EU greenlights an automotive SEP framework with built-in safeguards, and Sisvel slashes Wi-Fi 6 licensing fees to spur enterprise adoption. InterDigital’s $1B+ licensing deal with Samsung marks one of the sector’s biggest recent wins.

Stay tuned for more innovation shaping the IP and R&D landscape!